Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
Kyoichiro YazakiAtsushi SuzukiTsuyoshi ShigaYuichiro MinamiKotaro AraiKyomi AshiharaMorio ShodaNobuhisa HagiwaraPublished in: BMC cardiovascular disorders (2021)
Our findings showed that a baseline IVPG ≥ 30 mmHg was associated with an increased risk of experiencing SCD or appropriate ICD interventions among HCM patients who received ICDs for primary prevention. Combined with NSVT, which is a conventional risk factor, a baseline IVPG ≥ 30 mmHg may be a potential modifier of SCD risk in HCM patients.